CXCR6 and colorectal cancer: In a previous study, Wang et al. confirmed that CXCR6 was specifically highly expressed in CD8 + T cells and correlated positively with the prognosis of patients with colorectal cancer, while the deficiency of CXCR6 led to lower anti-PD-1 efficacy [23].